Cargando…
EVI2B Is a New Prognostic Biomarker in Metastatic Melanoma with IFNgamma Associated Immune Infiltration
SIMPLE SUMMARY: Ecotropic viral integration site 2B (EVI2B) is a protein-coding gene known as a lymphocyte-specific marker in peripheral blood. However, the prognostic value of EVI2B expression in metastatic melanoma tissue and its detailed profile of tumor-infiltrating lymphocytes are still unclear...
Autores principales: | Yonekura, Satoru, Ueda, Kosuke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8391972/ https://www.ncbi.nlm.nih.gov/pubmed/34439264 http://dx.doi.org/10.3390/cancers13164110 |
Ejemplares similares
-
EVI2B Is a Prognostic Biomarker and Is Correlated with Monocyte and Macrophage Infiltration in Osteosarcoma Based on an Integrative Analysis
por: Dai, Zhenlin, et al.
Publicado: (2023) -
Validation of a HLA-A2 tetramer flow cytometric method, IFNgamma real time RT-PCR, and IFNgamma ELISPOT for detection of immunologic response to gp100 and MelanA/MART-1 in melanoma patients
por: Xu, Yuanxin, et al.
Publicado: (2008) -
Peritumoral Immune Infiltrate as a Prognostic Biomarker in Thin Melanoma
por: Sabbatino, Francesco, et al.
Publicado: (2020) -
ITGAL as a prognostic biomarker correlated with immune infiltrates in melanoma
por: Deng, TengFei, et al.
Publicado: (2023) -
DIRAS2 Is a Prognostic Biomarker and Linked With Immune Infiltrates in Melanoma
por: Xue, Wenli, et al.
Publicado: (2022)